Quick Answer
BIO-TECHNE Corp reported Total Revenue of $1.22 billion for fiscal year 2025.
BIO-TECHNE Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.22B +5.2% |
$1.16B +2.0% |
$1.14B +2.8% |
$1.11B +18.7% |
$931.03M +26.0% |
$738.69M +3.5% |
| Revenue (ASC 606) | $1.22B +5.2% |
$1.16B +2.0% |
$1.14B +2.8% |
$1.11B +18.7% |
$931.03M +26.0% |
$738.69M +3.5% |
| Net Income | $73.40M -56.3% |
$168.10M -41.1% |
$285.26M +4.9% |
$272.05M +93.8% |
$140.41M -38.8% |
$229.30M +138.7% |
| Diluted EPS | $0.46 -56.2% |
$1.05 -40.3% |
$1.76 +6.0% |
$1.66 +90.8% |
$0.87 -85.1% |
$5.82 +135.6% |
| Total Assets | $2.56B -5.4% |
$2.70B +2.5% |
$2.64B +15.0% |
$2.29B +1.4% |
$2.26B +11.6% |
$2.03B +7.6% |
| Cash and Equivalents | $162.19M +6.8% |
$151.79M -15.9% |
$180.57M +4.6% |
$172.57M -13.3% |
$199.09M +35.8% |
$146.62M +45.3% |
| Stockholders Equity | $1.92B -7.3% |
$2.07B +5.2% |
$1.97B +15.6% |
$1.70B +8.9% |
$1.56B +13.2% |
$1.38B +18.5% |
| Operating Income | $102.25M -50.5% |
$206.69M -30.9% |
$298.94M +0.8% |
$296.59M +25.0% |
$237.30M +50.7% |
$157.42M +7.3% |
| Gross Profit | $790.27M +2.7% |
$769.73M -0.0% |
$769.82M +1.8% |
$756.50M +19.5% |
$632.85M +31.0% |
$483.19M +2.0% |
| Shares Outstanding | 154.97M -2.1% |
158.22M +0.4% |
157.64M +0.6% |
156.64M +302.1% |
38.96M +1.3% |
38.45M +1.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $295.88M | -0.4% | +3.3% |
| Revenue (ASC 606) | December 31, 2025 | $295.88M | -0.4% | +3.3% |
| Net Income | December 31, 2025 | $38.01M | +8.9% | -0.5% |
| Diluted EPS | December 31, 2025 | $0.24 | +9.1% | +0.0% |
| Total Assets | December 31, 2025 | $2.52B | -5.5% | -0.1% |
| Cash and Equivalents | December 31, 2025 | $172.88M | -2.6% | +19.3% |
| Stockholders Equity | December 31, 2025 | $2.01B | -3.2% | +2.3% |
| Operating Income | December 31, 2025 | $54.46M | +14.9% | +14.3% |
| Gross Profit | December 31, 2025 | $191.28M | -1.3% | +1.7% |
| Shares Outstanding | December 31, 2025 | 155.88M | -1.3% | +0.1% |
- BIO-TECHNE Corp reported Total Revenue of $1.22 billion for fiscal year 2025.
- BIO-TECHNE Corp showed an increase of +5.2% in Total Revenue compared to the prior fiscal year.
- BIO-TECHNE Corp reported Revenue (ASC 606) of $1.22 billion for fiscal year 2025.
- BIO-TECHNE Corp showed an increase of +5.2% in Revenue (ASC 606) compared to the prior fiscal year.
- BIO-TECHNE Corp reported Net Income of $73.40 million for fiscal year 2025.
- BIO-TECHNE Corp showed a decrease of -56.3% in Net Income compared to the prior fiscal year.
- BIO-TECHNE Corp reported Diluted EPS of $0.46 per share for fiscal year 2025.
- BIO-TECHNE Corp showed a decrease of -56.2% in Diluted EPS compared to the prior fiscal year.
- BIO-TECHNE Corp reported Total Assets of $2.56 billion for fiscal year 2025.
- BIO-TECHNE Corp showed a decrease of -5.4% in Total Assets compared to the prior fiscal year.
- BIO-TECHNE Corp reported Cash and Equivalents of $162.19 million for fiscal year 2025.
- BIO-TECHNE Corp showed an increase of +6.8% in Cash and Equivalents compared to the prior fiscal year.
- BIO-TECHNE Corp reported Stockholders Equity of $1.92 billion for fiscal year 2025.
- BIO-TECHNE Corp showed a decrease of -7.3% in Stockholders Equity compared to the prior fiscal year.
- BIO-TECHNE Corp reported Operating Income of $102.25 million for fiscal year 2025.
- BIO-TECHNE Corp showed a decrease of -50.5% in Operating Income compared to the prior fiscal year.
- BIO-TECHNE Corp reported Gross Profit of $790.27 million for fiscal year 2025.
- BIO-TECHNE Corp showed an increase of +2.7% in Gross Profit compared to the prior fiscal year.
- BIO-TECHNE Corp reported Shares Outstanding of 154.97 million shares for fiscal year 2025.
- BIO-TECHNE Corp showed a decrease of -2.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: